Abstract
Hepatocellular carcinoma (HCC) has an extremely unfavorable prognosis and lack of effective medication therapy. The excessive production of reactive oxygen species is the main cause of its initiation and progression, therefore the use of antioxidants could be a promising treatment. Biocompatible pristine C 60 fullerenes are powerful antioxidants, non-toxic and able to be accumulated in the liver. Therefore, their effects on HepG2 cells and liver state on rat HCC models were aimed to be discovered.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
More From: Annals of Oncology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
